[Drug therapy of hyperlipoproteinemias].
Dalmau Serra
J
J
Unidad de Nutrición, Hospital Infantil La Fe, Valencia.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000627:therapeutic use*; D025782:Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use
D000960:Hypolipidemic Agents; D009525:Niacin; D006903:Hydroxymethylglutaryl CoA Reductases; D025782:Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; D011341:Probucol
Tratamiento farmacológico de las hiperlipoproteinemias.